TKDA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Takeda Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 14.8 EUR

Market Cap: €46.4B

T	Takeda Pharmaceutical Co Ltd SWB:TKDA	JP
S	Shin-Etsu Chemical Co Ltd OTC:SHECF	JP
	Enact Holdings Inc NASDAQ:ACT	US
S	Siemens AG SIX:SIN	DE
	Societatea de Producere a Energiei Electrice in Hidrocentrale Hidroelectrica SA F:E28	RO
	Parker-Hannifin Corp NYSE:PH	US
	Nedap NV OTC:NDDLF	NL
	Ovid Therapeutics Inc NASDAQ:OVID	US
O	OPKO Health Inc XBER:XCY	US
B	Basler AG DUS:BSL	DE
N	Netbay PCL SET:NETBAY	TH
N	Navamedic ASA F:N1A	NO
P	Pakistan State Oil Company Ltd KAR:PSO	PK
T	TAG Immobilien AG XHAN:TEG	DE
F	First American Financial Corp F:Y1F	US

Profitability Summary

Takeda Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

65%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

69% > 65%

Low Operating Margin

Sustainable 3Y Average Operating Margin

10%

Declining Operating Margin

13% > 3%

Negative Net Margin

-4%

Low 3Y Average Net Margin

Declining Net Margin

7% > -4%

Exceptional Free Cash Flow Margin

11%

Strong 3Y Average Free Cash Flow Margin

12%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.